1. Actinic cheilitis: a systematic review of treatment options. (26th December 2020) Authors: Trager, M.H.; Farmer, K.; Ulrich, C.; Basset‐Seguin, N.; Herms, F.; Geskin, L.J.; Bouaziz, J.‐D.; Lebbé, C.; de Masson, A.; Bagot, M.; Dobos, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 4(2021) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Demodex-induced follicular mucinosis of the head and neck mimicking folliculotropic mycosis fungoides. (2019) Authors: Trager, M.H.; Queen, D.; Geskin, L.J. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and quality of life (QoL) in patients with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL) treated with chlormethine gel and other therapies: results from the PROVe study. (2019) Authors: Kim, E.J.; Geskin, L.J.; Querfeld, C.; Girardi, M.; Mink, D.R.; Williams, M.J.; Angello, J.T.; Bailey, W.L. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of chlormethine gel in patients with stage I–IIA mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): re-analysis of a randomized phase 2 study. (2019) Authors: Kim, E.J.; Geskin, L.J.; Mink, D.; Williams, M.; Angello, J.; Bailey, W.; Kim, Y. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of mogamulizumab in previously treated patients with less advanced mycosis fungoides (MF): results from the MAVORIC study. (2019) Authors: Scarisbrick, J.; Geskin, L.J.; Bagot, M.; Fisher, D.C.; Elmets, C.; Duvic, M.; Beylot-Barry, M.; Kim, E.J.; Moriya, J.; Leoni, M.; Zinzani, P.L. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EFFICACY OF MOGAMULIZUMAB IN PREVIOUSLY TREATED PATIENTS WITH LESS ADVANCED MYCOSIS FUNGOIDES: RESULTS FROM THE MAVORIC STUDY. (12th June 2019) Authors: Scarisbrick, J.; Geskin, L.J.; Bagot, M.; Fisher, D.C.; Elmets, C.; Duvic, M.; Beylot‐Barry, M.; Kim, E.J.; Moriya, J.; Leoni, M.; Zinzani, P.L. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lessons learned from gene expression profiling of cutaneous T‐cell lymphoma. (December 2013) Authors: Dulmage, B.O.; Geskin, L.J. Journal: British journal of dermatology Issue: Volume 169:Number 6(2013:Dec.) Page Start: 1188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome. (1st July 2016) Authors: Child, F.; Ortiz‐Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; Weichenthal, M.; Alves, R.; Quaglino, P.; Beylot‐Barry, M.; Cowan, R.; Geskin, L.J.; Pérez‐Ferriols, A.; Hellemans, P.; Elsayed, Y.; Phelps, C.; Forslund, A.; Kamida, M.; Zinzani, P.L. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome. (2nd June 2016) Authors: Child, F.; Ortiz‐Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; Weichenthal, M.; Alves, R.; Quaglino, P.; Beylot‐Barry, M.; Cowan, R.; Geskin, L.J.; Pérez‐Ferriols, A.; Hellemans, P.; Elsayed, Y.; Phelps, C.; Forslund, A.; Kamida, M.; Zinzani, P.L. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome3. (2nd June 2016) Authors: Child, F.; Ortiz‐Romero, P.L.; Alvarez, R.; Bagot, M.; Stadler, R.; Weichenthal, M.; Alves, R.; Quaglino, P.; Beylot‐Barry, M.; Cowan, R.; Geskin, L.J.; Pérez‐Ferriols, A.; Hellemans, P.; Elsayed, Y.; Phelps, C.; Forslund, A.; Kamida, M.; Zinzani, P.L. Journal: British journal of dermatology Issue: Volume 175:Number 1(2016) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗